Strides Pharma Science Limited

SBI Life Insurance increased its stake in Strides Pharma Science Limited from 4.25% to 4.76%, raising its shareholding from 3,912,939 to 4,387,939 shares. This represents an increase of 475,000 shares. The value of the additional shares bought is approximately ₹51.06 crore at a share price of ₹1074.90.

A pharmaceutical manufacturer engaged in developing and producing a diverse range of drug formulations for global distribution. The company operates across multiple therapy segments and maintains manufacturing facilities serving customers in over 100 countries. Strides Pharma has pursued strategic acquisitions and inorganic expansion to strengthen its market presence, diversify business segments, enhance therapy offerings, and build robust production infrastructure.

Joint venture between State Bank of India and BNP Paribas Cardif. Manages over Rs 4.7 lakh crore in total AUM with the flagship SBI Life Equity Fund alone holding over Rs 77,000 crore. One of India's largest private life insurers by AUM, with a multi-cap equity book deployed across ULIP and participating funds.